SH – Tom Webster PhD | Open Access Government

Figure 1: a) Nanotextured spinal implants now in over 30,000 humans with no cases of failure [2]. Such implants are being commercialized by Nanovis. b) Nanosensors now being used to detect the presence of bacteria, inflammatory cells, or bone-forming cells on implants. Such nanosensors can communicate to handheld devices and can respond in real-time to reverse adverse events. Such sensors have been implanted in sheep for up to 12 weeks showing the ability to promote bone growth.

Opinion: What are the barriers to innovation in medicine?

July 3, 2024

Thomas J. Webster, PhD provides a firsthand account of the obstacles hindering innovation in medicine, covering publishing, conferences, politics, funding, universities, and industry.

Carcinoid tumors are a type of slow-growing cancer that can arise in several places throughout your body. Carcinoid tumors, which are one subset of tumors called neuroendocrine tumors, usually begin in the digestive tract (stomach, appendix, small intestine, colon, rectum) or in the lungs. Site: Ovary

Are nanotextures enough to kill cancer cells?

March 20, 2024

Nanotextures on nanoparticles and implants to kill cancer cells in a more targeted manner may just be the key to tackling resistance to traditional cancer drugs.

Figure 1: Early research at Purdue University in the Webster lab that led to the formation of Nanovis, which now has over 3,000 FortiFixTM pedicle screws inserted in humans with no cases of implant failure, according to the Maude database. The industry standard of pedicle screw failures lies between 5 – 10% depending on the data assessed.

Opinion: Do universities help or hurt innovation?

January 10, 2024

Do Universities help or hurt innovation? Find out in this 25-year academic entrepreneur’s anecdotal perspective of starting companies and developing implants. Thomas J. Webster shares his opinion here.

Soap bubbles on a pink background,Texture background.

Artificial intelligence (AI) and biomaterials: A perfect BandAId™

October 6, 2023

Thomas J Webster, Ph.D., Professor and Entrepreneur, is investigating the potential of AI in medical applications and biomaterial production.

Virus in dirty dust smoke flow in the air Covid- virus 3D rendering - nanotechnology

How entrepreneurship and industry saved COVID fighting nanotechnology?

February 10, 2023

Here Thomas J. Webster, Ph.D. explores how Nanotechnology was crucial in the battle against COVID-19 and how entrepreneurship helped it thrive.

Archives